BEBO Health S.A.

BEBO Health S.A.

MLBBO.PA
BEBO Health S.A.undefined flagEuronext Paris
0.23
EUR
- -
- -
495,900.00Market Cap
BEBO Health S.A.
MLBBO.PA
(Euronext Paris)

Recent

price

0.23

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
FRC
0.07
0.15
3.76
- -
- -
3.1
- -
Revenue per Share
- -
0.01
0.04
- -
- -
0.01
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.01
0.02
0.36
- -
- -
0.36
- -
Book Value per Share
- -
-0.02
-1.06
- -
- -
0.35
- -
Tangible Book Value per Share
14
14
1
- -
- -
2
- -
Basic Weighted Avg Shares
1
2
5
6
5
7
24
Sales/Revenue/Turnover
5.01
10.01
6.33
5.33
7.13
-0.27
4.13
Operating Margin (%)
- -
- -
1
1
1
- -
3
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
1.04
- -
65.38
83.15
97.11
Effective Tax Rate (%)
5.01
10.01
1.06
1.31
0.23
0.19
0.17
Profit Margin (%)
- -
- -
3
1
-2
-2
-10
Working Capital
- -
- -
4
- -
- -
1
- -
LT Debt
- -
- -
1
8
8
8
15
Total Equity
- -
82.15
13.06
4.9
1.29
-0.03
0.21
Return on Invested Capital (%)
- -
82.15
2.22
2.97
3.94
0.46
0.44
Return on Capital (%)
- -
82.15
13.17
12.81
1.55
1.7
0.51
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
314.04%
82.05%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
18.69%
200.21%
Sales/Revenue/Turnover
- -
87.53%
249.57%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
5
2024
- -
- -
- -
- -
7
2025
- -
- -
- -
- -
24

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
BEBO Health S.A. is a Geneva-based company specializing in the online distribution of health, sports, and wellness products for both individual consumers and professional clients. Founded in 2019, the company offers a diverse product portfolio including slimming devices under the Slim Sonic brand, body contouring solutions for cellulite treatment branded as Celliss, personal air conditioning systems sold under the Snø brand, and nutrition products marketed through the Maiday and Natur'effect brands. BEBO Health operates primarily through e-commerce channels, leveraging digital platforms to reach its customers across various regions. In September 2025, BEBO Health announced a significant strategic transformation, rebranding to BE MAKER S.A. and adopting a new growth strategy focused on consumer goods that valorize sports and cultural legends. This strategic shift included the acquisition of 100% of MM Winemaker SA, a Swiss company holding exclusive distribution contracts for globally recognized icons. The acquisition was executed through a reverse takeover (RTO) transaction valued at €129 million, reflecting a major expansion and repositioning of the company's business model. With this transformation, BE MAKER seeks to transfer its listing to the Euronext Growth segment, aiming for enhanced market visibility and growth potential. BEBO Health S.A. serves the health, sport, and well-being industry segments, targeting consumers seeking innovative wellness technologies and products. Its operations extend primarily within European markets, including France and Switzerland, where it is headquartered. The company is a subsidiary of CES Management SA. This repositioning aims to capture greater market share in consumer goods tied to prestigious sports and cultural imagery, marking a significant evolution from its original health and wellness product orientation.